Investigators looked into whether there was any clinical relevance for inflammatory biomarkers in the setting of electroconvulsive therapy (ECT) for the treatment of depression.
Researchers assessed the association between adipose tissue dysfunction and osteoarthritis-related pain in women.
For patients with six immune-mediated inflammatory diseases, the risk for CVD is increased in association with glucocorticoid dose.
A phase 3 study evaluating the efficacy and safety of ruxolitinib for the treatment of COVID-19 did not meet its primary end point.
Researchers evaluated the clinical effect of baricitinib on mortality and morbidity in patients with COVID-19.
Investigators compared automated imaging measures of inflammation with clinical exam assessment of activity in uveitis patients to determine efficacy.
Neurologic disturbances in patients with coronavirus disease 2019 were accompanied by evidence of cytokine release syndrome.
Adult patients with current or previous SARS-CoV-2 can develop a hyperinflammatory syndrome.
Researchers identified factors related to autoantibody positivity and development of inflammatory arthritis/rheumatoid arthritis, based on family history of disease.
Researchers evaluated a specific phenotype of COVID-19-associated hyperinflammation and its association with escalation of patient care.
